Kahrbio
kahrbio.base44.app
Actively hiring
Oncology Therapeutics
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
2
aMoon, Flerie
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 2026
Formerly KAHR Bio (kahrbio.com)
Backed byfrom the funds' portfolios and accelerator catalogs
aMoon 
Flerie Similar startupsby what they do, their industry and backers
Creating neoantigens by design… …to transform cancer treatments into cures. ATP IS DEVELOPING THE NEXT GENERATION OF TRANSFORMATIVE LIFE…
Innovating life-changing medicines for cancer patients. At Kumquat, we're on a mission to transform cancer treatment by delivering durable…
Yemaachi is creating the world's most diverse cancer bio-database to develop the next generation of cancer drugs that are effective in…
CAR T therapies with more durable responses, improving treatment outcomes and saving the lives of patients with refractory cancers.
At ITM, precision drives everything - from isotope manufacturing to cancer treatment—improving outcomes and delivering what patients and…
What if we made as many cancer drugs next year as we have in the last decade?
Overview
KAHR Bio: Pioneering Immunotherapeutics for Advanced Cancer Treatment.